Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
AL

ALNY

Market Closed

Alnylam Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnology
US
2.50K employees
CEO: Yvonne L. Greenstreet
Founded: 2004
$216.12
+$0.00(+NaN%)
Market Cap
28.92B
Beta
0.27
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Forecasting Analysis
AI-powered predictions and statistical risk modeling for short-term price movements
AI Insight:
AI short-term forecasts indicate modest downside risk with declining momentum. Analyst consensus shows strong coverage and a wide range, reflecting divergent views despite broadly aligned optimism. This combination suggests elevated near-term uncertainty amid long-term growth potential.
Current Price
N/A

Last closing price

Price Prediction
Machine learning prediction based on historical price patterns
Period:
Analyst Price Target for ALNY

Loading analyst price targets...

Wall Street Forecasts

Revenue Forecast

Past Growth

N/A

Based on Historical CAGR

Forward Growth

N/A

Projected CAGR

Analyst Accuracy

0%

Estimate Accuracy

Revenue Analysis
Comparison of Actual and Estimated Revenues

Loading chart data...

Revenue growth steady at 0.0%.

Operating Profitability Forecast

Past Growth

N/A

EBITDA Historical CAGR

Forward Growth

N/A

EBITDA Projected CAGR

Analyst Accuracy

0%

Estimate Accuracy

EBITDA Analysis
Comparison of Actual and Estimated EBITDA

Loading chart data...

EBITDA maintaining 0.0% trajectory.

Earnings Per Share Forecast

Past Growth

N/A

EPS Historical CAGR

Forward Growth

N/A

EPS Projected CAGR

Analyst Accuracy

0%

Estimate Accuracy

EPS Analysis
Comparison of Actual and Estimated Earnings Per Share

Loading chart data...

EPS growth stable around 0.0%.

Explore ALNY

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

ALNY in the Healthcare

Large Cap
Healthcare

Browse sector stocks →

Biotechnology

Browse industry stocks →